Prostate cancer: Genomic drivers of resistance to AR therapies

被引：6
|
作者：
Kelsey R.
机构：
来源：
Nature Reviews Urology | 2018年 / 15卷 / 4期
关键词：
D O I：
10.1038/nrurol.2018.18
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：202 / 202
相关论文
共 50 条
  • [21] Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
    Marcotte, Richard
    Sayad, Azin
    Brown, Kevin R.
    Sanchez-Garcia, Felix
    Reimand, Jueri
    Haider, Maliha
    Virtanen, Carl
    Bradner, James E.
    Bader, Gary D.
    Mills, Gordon B.
    Pe'er, Dana
    Moffat, Jason
    Neel, Benjamin G.
    CELL, 2016, 164 (1-2) : 293 - 309
  • [22] Genomic instability and hypoxia as co-drivers of prostate cancer aggression.
    Bristow, Robert G.
    CANCER RESEARCH, 2021, 81 (13)
  • [23] AR enhancer and locus genomic alterations as cell-free DNA biomarkers of primary resistance to AR-directed treatment of metastatic prostate cancer.
    Maher, Chris
    Dang, Ha X.
    Chauhan, Pradeep S.
    Ellis, Haley
    Feng, Wenjia
    Harris, Peter
    Smith, Grace
    Qiao, Mark
    Dienstbach, Katherine
    Beck, Rachel
    Atkocius, Andrew
    Qaium, Faridi
    Luo, Jingqin
    Michalski, Jeff
    Picus, Joel
    Pachynski, Russell Kent
    Chaudhuri, Aadel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Introduction to "Molecular drivers of prostate cancer development, progression, and resistance to therapy"
    Barbieri, Christopher E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 367 - 367
  • [25] Cognitive effects of androgen receptor (AR) directed therapies for advanced cancer of the prostate (COGCaP).
    Van, Julie
    Penson, David F.
    Rademaker, Alfred
    Jackson, James C.
    Moses, Kelvin A.
    Morgans, Alicia K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11): : 1028 - 1038
  • [27] Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
    Monteiro, Catia
    Sousa, Marta Velho
    Ribeiro, Ricardo
    Mauricio, Joaquina
    Fraga, Avelino
    Medeiros, Rui
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [28] Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
    Cátia Monteiro
    Marta Velho Sousa
    Ricardo Ribeiro
    Joaquina Maurício
    Avelino Fraga
    Rui Medeiros
    Medical Oncology, 2013, 30
  • [29] AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer
    Liu, Chengfei
    Yang, Joy C.
    Armstrong, Cameron M.
    Lou, Wei
    Liu, Liangren
    Qiu, Xiaomin
    Zou, Binhao
    Lombard, Alan P.
    D'Abronzo, Leandro S.
    Evans, Christopher P.
    Gao, Allen C.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1875 - 1886
  • [30] COMBINATION THERAPIES TO PREVENT RESISTANCE TO ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER
    Li, Zhenghong
    Sun, Carrie Qi
    Arnold, Rebecca
    Petros, John A.
    Moreno, Carlos S.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E320 - E320
12345